NIKKEI 225
38,806.50 +316.33 (+0.82%) HANG SENG
18,461.94 +36.98 (+0.20%) CRUDE OIL
74.48 +0.41 (+0.55%) GOLD FUTURES
2,386.90 +11.40 (+0.48%) DOW
38,807.33 +96.04 (+0.25%) Bitcoin GBP
55,416.16 -74.88 (-0.13%)
Heart Test Laboratories, Inc. (HSCS)
After hours:
| Previous close | 5.15 |
| Open | 5.34 |
| Bid | 5.36 x 100 |
| Ask | 5.58 x 100 |
| Day's range | 5.20 - 5.69 |
| 52-week range | 5.10 - 110.00 |
| Volume | |
| Avg. volume | 46,320 |
| Market cap | 3.639M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -35.00 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 67.50 |
GlobeNewswireHeartSciences Regains Compliance with Nasdaq Listing Requirements
Southlake, TX, June 04, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that on June 3, 2024, the Company received formal notice from the Listing Qualifications Staff of the Nasdaq Stock Market LLC indicating that HeartSciences has regained
- GlobeNewswire
HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio
Granted Indian Patent for its MyoVista® Wavelet TechnologySouthlake, Texas, May 20, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that it has been granted Indian Patent Application 201817014481 by the Indian Patent Office (IPO). To date,
- GlobeNewswire
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
Patent covers use of AI-ECG for any echo measure of diastolic function, which is crucial for heart screening and early detection of heart diseaseSouthlake, Texas, April 24, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that its European P
